Research graph
References from Epstein–Barr virus post‐transplant lymphoproliferative disease and virus‐specific therapy: pharmacological re‐activation of viral target genes with arginine butyrate. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1002/bjs.18004619704
10.1002/bjs.18004619704 · External reference
10.1016/s0140-6736(64)92354-2
10.1016/s0140-6736(64)92354-2 · External reference
10.1136/bmj.4.5633.746
10.1136/bmj.4.5633.746 · External reference
10.1001/archsurg.1978.01370160119020
10.1001/archsurg.1978.01370160119020 · External reference
Epstein–Barr virus–associated diseases in humans
2000 · External reference
10.1136/jcp.53.4.248
10.1136/jcp.53.4.248 · External reference
10.1097/00062752-200001000-00011
10.1097/00062752-200001000-00011 · External reference
10.1001/jama.278.6.510
10.1001/jama.278.6.510 · External reference
10.1084/jem.187.9.1395
10.1084/jem.187.9.1395 · External reference
A re‐evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers
10.4049/jimmunol.162.3.1827 · 1999 · External reference
Unresolved reference
1996 · External reference
10.1128/jvi.61.5.1743-1746.1987
10.1128/jvi.61.5.1743-1746.1987 · External reference
10.1016/0042-6822(91)90893-g
10.1016/0042-6822(91)90893-g · External reference
10.1073/pnas.71.3.631
10.1073/pnas.71.3.631 · External reference
10.1016/s0065-230x(08)60470-4
10.1016/s0065-230x(08)60470-4 · External reference
10.1073/pnas.59.1.94
10.1073/pnas.59.1.94 · External reference
10.1007/bf00201468
10.1007/bf00201468 · External reference
10.1038/2424
10.1038/2424 · External reference
10.1073/pnas.95.23.13765
10.1073/pnas.95.23.13765 · External reference
10.1038/26683
10.1038/26683 · External reference
10.1097/00005792-199103000-00005
10.1097/00005792-199103000-00005 · External reference
10.1002/1097-0142(19941101)74:9<2436::aid-cncr2820740908>3.0.co;2-s
10.1002/1097-0142(19941101)74:9<2436::aid-cncr2820740908>3.0.co;2-s · External reference
10.1002/ajh.2830180110
10.1002/ajh.2830180110 · External reference
10.1093/infdis/156.2.273
10.1093/infdis/156.2.273 · External reference
Epstein–Barr virus transmission via the donor organs in solid organ transplantation: polymerase chain reaction and restriction fragment length polymorphism analysis of IR2, IR3, and IR4
10.1128/jvi.65.2.976-980.1991 · 1991 · External reference
10.1097/00007890-199306000-00040
10.1097/00007890-199306000-00040 · External reference
10.1136/thx.50.2.205
10.1136/thx.50.2.205 · External reference
10.1097/00007890-199104000-00041
10.1097/00007890-199104000-00041 · External reference
10.1097/00007890-198906000-00005
10.1097/00007890-198906000-00005 · External reference
10.1097/00007890-198804000-00011
10.1097/00007890-198804000-00011 · External reference
10.1016/s0272-6386(12)80823-7
10.1016/s0272-6386(12)80823-7 · External reference
10.1093/ajcp/101.5.590
10.1093/ajcp/101.5.590 · External reference
10.1002/1097-0142(19931101)72:9<2568::aid-cncr2820720910>3.0.co;2-d
10.1002/1097-0142(19931101)72:9<2568::aid-cncr2820720910>3.0.co;2-d · External reference
Rapid development of lymphoma following liver transplantation in a recipient with hepatitis B and primary hemochromatosis
1993 · External reference
Malignant lymphomas in organ transplant recipients
1981 · External reference
Discrimination of Epstein–Barr virus‐related post‐transplant lymphoproliferations from acute rejection in lung allograft recipients
1995 · External reference
Epstein–Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation
10.1182/blood.v71.5.1234.1234 · 1988 · External reference
10.1183/09031936.94.07030612
10.1183/09031936.94.07030612 · External reference
Post‐transplant mediastinal Burkitt‐like lymphoma. Diagnosis by cytologic and flow cytometric analysis of pleural fluid
1990 · External reference
10.1002/1097-0142(19940615)73:12<3064::aid-cncr2820731227>3.0.co;2-0
10.1002/1097-0142(19940615)73:12<3064::aid-cncr2820731227>3.0.co;2-0 · External reference
10.1097/00007890-199606270-00010
10.1097/00007890-199606270-00010 · External reference
10.1056/nejm199012203232502
10.1056/nejm199012203232502 · External reference
Overview of posttransplant B‐cell lymphoproliferative disorders
1999 · External reference
10.1007/s002810050041
10.1007/s002810050041 · External reference
10.1097/00007890-199307000-00016
10.1097/00007890-199307000-00016 · External reference
Post‐transplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine‐based immunosuppression
1991 · External reference
10.1097/00007890-199911270-00015
10.1097/00007890-199911270-00015 · External reference
10.1006/bcmd.1998.0178
10.1006/bcmd.1998.0178 · External reference
10.1056/nejm199404283301703
10.1056/nejm199404283301703 · External reference
A monoclonal immunoblastic sarcoma in donor cells bearing Epstein–Barr virus genomes following allogeneic marrow grafting for acute lymphoblastic leukemia
10.1182/blood.v60.1.180.180 · 1982 · External reference
10.1002/j.1460-2075.1986.tb04450.x
10.1002/j.1460-2075.1986.tb04450.x · External reference
10.1021/bi00329a034
10.1021/bi00329a034 · External reference
Characterization of the Epstein–Barr virus‐encoded thymidine kinase expressed in heterologous eucaryotic and procaryotic systems
10.1128/jvi.62.10.3892-3895.1988 · 1988 · External reference
10.1126/science.1317968
10.1126/science.1317968 · External reference
Prolonged inhibitory effect of 9‐(1,3‐dihydroxy‐2‐propoxymethyl)guanine against replication of Epstein–Barr virus
10.1128/jvi.50.1.50-55.1984 · 1984 · External reference
10.1001/jama.259.3.384
10.1001/jama.259.3.384 · External reference
10.7326/0003-4819-107-2-348
10.7326/0003-4819-107-2-348 · External reference
10.1165/ajrcmb/8.6.655
10.1165/ajrcmb/8.6.655 · External reference
10.1073/pnas.91.8.3054
10.1073/pnas.91.8.3054 · External reference
10.1007/bf01309995
10.1007/bf01309995 · External reference
10.1002/1097-0142(19830101)51:1<9::aid-cncr2820510104>3.0.co;2-4
10.1002/1097-0142(19830101)51:1<9::aid-cncr2820510104>3.0.co;2-4 · External reference
10.1016/0277-5379(87)90109-x
10.1016/0277-5379(87)90109-x · External reference
10.1111/j.1365-2141.1994.tb05073.x
10.1111/j.1365-2141.1994.tb05073.x · External reference
10.1056/nejm199301143280202
10.1056/nejm199301143280202 · External reference
10.1097/00062752-199502020-00002
10.1097/00062752-199502020-00002 · External reference
Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease [see comments]
1999 · External reference
Butyrate‐induced G1 arrest results from p21‐independent disruption of retinoblastoma protein‐mediated signals
1998 · External reference
10.1006/excr.1998.4370
10.1006/excr.1998.4370 · External reference
Initiation of growth arrest and apoptosis of MCF‐7 mammary carcinoma cells by tributyrin, a triglyceride analogue of the short‐chain fatty acid butyrate, is associated with mitochondrial activity
1999 · External reference
10.1002/(sici)1097-0215(19990505)81:3<411::aid-ijc15>3.0.co;2-f
10.1002/(sici)1097-0215(19990505)81:3<411::aid-ijc15>3.0.co;2-f · External reference
Induction of apoptosis by monosaccharide butyrate stable derivatives in chronic lymphocytic leukemia cells
1999 · External reference
Butyrate‐induced apoptotic cascade in colonic carcinoma cells: modulation of the beta‐catenin‐Tcf pathway and concordance with effects of sulindac and trichostatin A but not curcumin
1999 · External reference
The apoptotic effects and synergistic interaction of sodium butyrate and MG132 in human retinoblastoma Y79 cells
1999 · External reference
10.1016/0006-291x(87)90932-6
10.1016/0006-291x(87)90932-6 · External reference
10.1016/s0140-6736(78)92999-9
10.1016/s0140-6736(78)92999-9 · External reference
10.1056/nejm198204153061506
10.1056/nejm198204153061506 · External reference
10.1016/s0140-6736(82)90210-0
10.1016/s0140-6736(82)90210-0 · External reference
10.1016/s0022-3476(82)80125-x
10.1016/s0022-3476(82)80125-x · External reference
10.1056/nejm198512193132502
10.1056/nejm198512193132502 · External reference
10.1182/blood.v85.2.552.552
10.1182/blood.v85.2.552.552 · External reference
Polymorphic diffuse B‐cell hyperplasias and lymphomas in renal transplant recipients
1981 · External reference
10.1038/2281056a0
10.1038/2281056a0 · External reference
Epstein–Barr viral DNA in tissues of Hodgkin’s disease
1987 · External reference
10.1097/00000658-198309000-00012
10.1097/00000658-198309000-00012 · External reference
10.1056/nejm198803243181203
10.1056/nejm198803243181203 · External reference
Lymphoepithelial carcinoma of the stomach with Epstein–Barr virus demonstrated by polymerase chain reaction
1990 · External reference
Epstein–Barr virus‐associated gastric adenocarcinoma
1992 · External reference
10.1056/nejm199501053320103
10.1056/nejm199501053320103 · External reference
Epstein–Barr virus in epithelial cell tumors: a breast cancer study
1995 · External reference
Treatment of Epstein–Barr virus (EBV)‐associated lymphomas and PTLD using arginine butyrate to induce viral TK gene expression: initial findings of a phase I/II trial
1999 · External reference
Phase I/II trial of arginine butyrate to induce viral TK gene expression in Epstein–Barr virus (EBV)‐associated lymphomas
2000 · External reference
